|
National Stock Number(NSN): 6505-01-256-8403 (6505012568403, 012568403)
| NIIN: |
01-256-8403 |
Item Name: |
FAT EMULSION INJECTION |
INC: |
35184
|
| FSC: |
6505
|
Assignment Date: |
|
CRIT: |
|
IIG: |
35184 |
| ISC: |
5 |
Date Standardized: |
|
HMIC: |
|
DODIC: |
|
| NSC: |
8 |
Cancellation Date: |
May-24-1997 |
PMIC: |
|
FIIG: |
A45100 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
E |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
|
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
132015 |
66159
|
ALPHA THERAPEUTIC CORP |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
NDC49669-1320-15 |
66159
|
ALPHA THERAPEUTIC CORP |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
SOYACAL 20% INJECTION |
66159
|
ALPHA THERAPEUTIC CORP |
H |
5 |
1 |
|
|
|
|
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
1.200 PERCENTAGE,W/V EGG YOLK PHOSPHOLIPIDS ACTIVE INGREDIENT AND 2.210 PERCENTAGE,W/V GLYCERIN ACTIVE INGREDIENT AND 20.000 PERCENTAGE,W/V SOYBEAN OIL ACTIVE INGREDIENT |
| CBBL |
FEATURES PROVIDED |
STERILE |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
500.000 MILLILITERS |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
10 |
| CSGS |
ADMINISTRATION |
INTRAVENOUS INFUSION |
| PKTY |
UNIT PACKAGE TYPE |
PACKAGE |
|